Mavacamten will lessen the extent or result of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may possibly reduce systemic exposures of ethinyl estradiol and progestin, which may bring about contraceptive failure or an increase in https://lindseyx579vus9.wikicarrier.com/user